Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study

Creative Commons License

Frix A., Heaney L. G., Dahlen B., Mihaltan F., Sergejeva S., Popovic-Grle S., ...More

ERJ OPEN RESEARCH, vol.8, no.4, 2022 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 8 Issue: 4
  • Publication Date: 2022
  • Doi Number: 10.1183/23120541.00273-2022
  • Journal Name: ERJ OPEN RESEARCH
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, Directory of Open Access Journals
  • Istanbul University Affiliated: No


Introduction Treatment with biologics for severe asthma is informed by international and national guidelines and defined by national regulating bodies, but how these drugs are used in real-life is unknown.